Squamous Cell Non-small Cell Lung Cancer

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial update shows ALE.P03 as monotherapy being studied in adults with selected advanced or metastatic CLDN1+ solid tum…

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]

  This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…

• CLINICAL_TRIALS research · 2024-12-27
  Clinical Trial Update: Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study [Phase 2]

  This Clinical Trial Update describes a Phase 2, single-arm multicenter study evaluating the combination of sintilimab with nab-paclitaxel an…